ACCESSION: MSBNK-SMB_Measured-HSA033P0173017
RECORD_TITLE: Uncharacterized; LC-ESI-QTOF; MS2; NEGATIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.15, Processed 2025.02.15, Annotated 2025.04.01, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Liang et al. J Pharm Biomed Anal. 2022, 214, 114718
COMMENT: This is an averaged mass spectra data created by integrating product ion scan data obtained from the follwing DDA dataset.
COMMENT: DATASET_ID MTBLS3854
COMMENT: DATASET_TITLE Long-term low-dose ionizing radiation induced chromosome-aberration-specific metabolic phenotype changes in radiation workers
COMMENT: DATASET_AUTHORS Xinjun Wang
COMMENT: MS1_M/Z_AVERAGED_THRES 20.000
COMMENT: MS2_M/Z_AVERAGED_THRES 20.000
COMMENT: DATASET_FILE_NUM 50
COMMENT: NUM_AVERAGED_SPEC 17
COMMENT: RAW_SPEC {'C18neg_6351': {'bp': 2115.0, 'sum': 3272.0}, 'D122neg_6634': {'bp': 1630.0, 'sum': 2598.0}, 'D73neg_6395': {'bp': 1588.0, 'sum': 2459.0}, 'D168neg_6389': {'bp': 1498.0, 'sum': 2452.0}, 'D207neg_6532': {'bp': 1408.0, 'sum': 2328.0}, 'D143neg_6301': {'bp': 1303.0, 'sum': 1963.0}, 'D84neg_6391': {'bp': 1301.0, 'sum': 1976.0}, 'D84neg_6402': {'bp': 1144.0, 'sum': 1946.0}, 'C11neg_6244': {'bp': 1067.0, 'sum': 1756.0}, 'D146neg_6136': {'bp': 1058.0, 'sum': 1645.0}, 'D99neg_6064': {'bp': 1003.0, 'sum': 1545.0}, 'D84neg_6309': {'bp': 895.0, 'sum': 1554.0}, 'C8neg_5889': {'bp': 893.0, 'sum': 1381.0}, 'C4neg_6126': {'bp': 740.0, 'sum': 1129.0}, 'D121neg_6357': {'bp': 691.0, 'sum': 1180.0}, 'D171neg_6090': {'bp': 683.0, 'sum': 1305.0}, 'D87neg_6067': {'bp': 589.0, 'sum': 984.0}}
COMMENT: RETENTION_TIME_STDEV 0.366
COMMENT: PRECURSOR_M/Z_RAW 173.092711
COMMENT: PRECURSOR_M/Z_STDEV 0.000691
COMMENT: PRECURSOR_IN_MS1 mz 173.092830; int 25.867; delta(ppm) 0.104302
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 19.339; C6H15N4P; [M-H]1; delta(ppm) -19.339453
COMMENT: PROPOSED_MF SevenGoldenRules 2.165; C7H14N2O3; [M-H]1; delta(ppm) -2.165421
COMMENT: PROPOSED_MF MS-FINDER 3.305; C7H14N2O3; [M-H]-; delta(ppm) -2.177414
COMMENT: PROPOSED_MF SIRIUS6_Sirius 2.000; C7H14N2O3; [M-H]-; delta(ppm) -2.177414
COMMENT: PROPOSED_MF SIRIUS6_Sirius -2.605; C5H12N5O2; [M-H]-; delta(ppm) 5.579513
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.990; C7H14N2O3; [M-H]-; delta(ppm) -2.177414
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.010; C5H12N5O2; [M-H]-; delta(ppm) 5.579513
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; CAXIQKXPSQYDIR-UHFFFAOYSA-N; [M-H]-; O=C(C=CC=1C=CC=CC1)C(C)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; MDFATIDEXXOYPV-UHFFFAOYNA-N; [M-H]-; CC1CCC2=C1C=CC(=O)C=C2C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; PHEPHOADHFLZJS-FNORWQNLSA-N; [M-H]-; CC(=O)\C=C\CCC1=CC=CC=C1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; SQESYXTWWGWCFK-UHFFFAOYNA-N; [M-H]-; CC1CCC(=O)C2=CC(C)=CC=C12
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.000; ULRYRAHIBWLZKC-XYOKQWHBSA-N; [M-H]-; CC(C)\C=C(/C=O)C1=CC=CC=C1
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.232; JRLGPAXAGHMNOL-LURJTMIESA-N; [M-H]-; N-Acetylornithine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.076; DATAGRPVKZEWHA-UHFFFAOYNA-N; [M-H]-; L-Theanine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.867; STKYPAFSDFAEPH-UHFFFAOYNA-N; [M-H]-; Glycyl-Valine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.867; SRXKAYJJGAAOBP-LURJTMIESA-N; [M-H]-; N(5)-acetyl-L-ornithine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.763; KBZOEWOSIUJWIO-GTZZQALGNA-N; [M-H]-; Calystegine N1
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.711; IOUPEELXVYPCPG-UHFFFAOYNA-N; [M-H]-; Valyl-Glycine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.659; JXIQKLAZYWZTRA-UHFFFAOYNA-N; [M-H]-; Gly-Norvaline
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.659; KLPJXDPPMSJWKI-LURJTMIESA-N; [M-H]-; N(6)-formyl-L-lysine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.659; GYBSHHFMEYHQNH-CGAWKTQKNA-N; [M-H]-; UNPD122367
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.607; PGYJBAGGGAUHGV-JKUQZMGJSA-N; [M-H]-; 5-(Hydroxy-Methyl-Amino)-3-Methyl-Pyrrolidine-2-Carboxylic Acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.607; BOASPQITGIFGOF-UHFFFAOYSA-N; [M-H]-; [methyl(nitroso)amino]methyl 2,2-dimethylpropanoate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.607; CBGXVHOGJBNZLS-UHFFFAOYSA-N; [M-H]-; 2-piperidin-4-ylethyl nitrate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.607; LIEIRDDOGFQXEH-LURJTMIESA-N; [M-H]-; (2S)-6-amino-2-formamidohexanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.607; YVAWVOLVGYCKGM-ZCFIWIBFSA-N; [M-H]-; acetyl (2R)-2,5-diaminopentanoate
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.607; AXURSAQTBIXUTE-UHFFFAOYSA-N; [M-H]-; 2-(carbamoylamino)-3-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.607; JUIBQJHHPDRAGP-UHFFFAOYSA-N; [M-H]-; 2-(carbamoylamino)-4-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.607; KCBOUBDARKABRM-UHFFFAOYSA-N; [M-H]-; N-[3-(N-hydroxyacetamido)propyl]acetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.607; NOLLPBJENGJGNO-UHFFFAOYSA-N; [M-H]-; Valanimycin
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.607; VBXVTHZKPBZQDB-UHFFFAOYSA-N; [M-H]-; N-[(4-amino-3-hydroxyoxolan-2-yl)methyl]acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; DATAGRPVKZEWHA-UHFFFAOYNA-N; [M-H]-; L-Theanine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; IOUPEELXVYPCPG-UHFFFAOYNA-N; [M-H]-; Valyl-Glycine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; JRLGPAXAGHMNOL-LURJTMIESA-N; [M-H]-; N-Acetylornithine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; JXIQKLAZYWZTRA-UHFFFAOYNA-N; [M-H]-; Gly-Norvaline
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; STKYPAFSDFAEPH-UHFFFAOYNA-N; [M-H]-; Glycyl-Valine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; KBZOEWOSIUJWIO-GTZZQALGNA-N; [M-H]-; Calystegine N1
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; KLPJXDPPMSJWKI-LURJTMIESA-N; [M-H]-; N(6)-formyl-L-lysine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; SRXKAYJJGAAOBP-LURJTMIESA-N; [M-H]-; N(5)-acetyl-L-ornithine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; PGYJBAGGGAUHGV-JKUQZMGJSA-N; [M-H]-; 5-(Hydroxy-Methyl-Amino)-3-Methyl-Pyrrolidine-2-Carboxylic Acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; GYBSHHFMEYHQNH-CGAWKTQKNA-N; [M-H]-; UNPD122367
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; BOASPQITGIFGOF-UHFFFAOYSA-N; [M-H]-; [methyl(nitroso)amino]methyl 2,2-dimethylpropanoate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; CBGXVHOGJBNZLS-UHFFFAOYSA-N; [M-H]-; 2-piperidin-4-ylethyl nitrate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; LIEIRDDOGFQXEH-LURJTMIESA-N; [M-H]-; (2S)-6-amino-2-formamidohexanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; YVAWVOLVGYCKGM-ZCFIWIBFSA-N; [M-H]-; acetyl (2R)-2,5-diaminopentanoate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; AXURSAQTBIXUTE-UHFFFAOYSA-N; [M-H]-; 2-(carbamoylamino)-3-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; JUIBQJHHPDRAGP-UHFFFAOYSA-N; [M-H]-; 2-(carbamoylamino)-4-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; KCBOUBDARKABRM-UHFFFAOYSA-N; [M-H]-; N-[3-(N-hydroxyacetamido)propyl]acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; VBXVTHZKPBZQDB-UHFFFAOYSA-N; [M-H]-; N-[(4-amino-3-hydroxyoxolan-2-yl)methyl]acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.139; DATAGRPVKZEWHA-YFKPBYRVSA-N; [M-H]-; (2S)-2-amino-5-(ethylamino)-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.376; STKYPAFSDFAEPH-LURJTMIESA-N; [M-H]-; (2S)-2-[(2-aminoacetyl)amino]-3-methylbutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.689; JRLGPAXAGHMNOL-LURJTMIESA-N; [M-H]-; (2S)-2-acetamido-5-aminopentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.251; SRXKAYJJGAAOBP-LURJTMIESA-N; [M-H]-; (2S)-5-acetamido-2-aminopentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.229; IOUPEELXVYPCPG-LURJTMIESA-N; [M-H]-; 2-[[(2S)-2-amino-3-methylbutanoyl]amino]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.223; DFRGVMDKNSXRPF-UHFFFAOYSA-N; [M-H]-; 4,5-dimethoxy-1,3-dimethylimidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.119; YMUAXKYTHNCMAS-UHFFFAOYSA-N; [M-H]-; [butyl(nitroso)amino]methyl acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.116; RABAKMVAMFRJLX-UHFFFAOYSA-N; [M-H]-; ethyl N-butyl-N-nitrosocarbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.116; CSGMPGJJBQAQLG-UHFFFAOYSA-N; [M-H]-; 2-methoxy-2,6-dimethyl-4-nitrosomorpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.115; JUIBQJHHPDRAGP-UHFFFAOYSA-N; [M-H]-; 2-(carbamoylamino)-4-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.113; KGWHMDCQVDMTNZ-UHFFFAOYSA-N; [M-H]-; 2-(butylcarbamoylamino)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.113; AXURSAQTBIXUTE-UHFFFAOYSA-N; [M-H]-; 2-(carbamoylamino)-3-methylpentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.113; CNZVQCYTFMIBMO-UHFFFAOYSA-N; [M-H]-; 1,3-bis(methoxymethyl)imidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.112; BQNWWHFSEXYHKU-UHFFFAOYSA-N; [M-H]-; 6-(carbamoylamino)hexanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.112; ABUWPGZRKFDPIX-UHFFFAOYSA-N; [M-H]-; N-(diethylcarbamoyl)-N-methoxyformamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.112; LNLRCQQTGATDQI-RFZPGFLSSA-N; [M-H]-; methyl (2R)-2-[[(2R)-2-aminopropanoyl]amino]propanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.111; XQBWWSOQRZVLPX-UHFFFAOYSA-N; [M-H]-; 2-amino-3-morpholin-4-ylpropanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.111; ZTLADCZOZNSKIC-UHFFFAOYSA-N; [M-H]-; butyl N-ethyl-N-nitrosocarbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.111; CRTBNFJSWPZSQM-UHFFFAOYSA-N; [M-H]-; 2-(carbamoylamino)hexanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.111; ZOAHHDMHCCTJEJ-UHFFFAOYSA-N; [M-H]-; 3,3-dimethoxycyclobutane-1-carbohydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.111; GSMTYNSCEYOUIG-UHFFFAOYSA-N; [M-H]-; 3-acetamido-N-(2-hydroxyethyl)propanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.111; LMWPPEPDTZCYNZ-RXMQYKEDSA-N; [M-H]-; (2R)-5-amino-2-(dimethylamino)-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.111; JDFUKHCIGQJBDY-UHFFFAOYSA-N; [M-H]-; 2-(carbamoylamino)-3,3-dimethylbutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.111; GADFBWUKVIMHSB-WEVVVXLNSA-N; [M-H]-; [(E)-(2-methoxy-2-methylpropylidene)amino] N-methylcarbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.111; YKZZHGMZKDLRRR-UHFFFAOYSA-N; [M-H]-; methyl 2-[3-aminopropanoyl(methyl)amino]acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.111; PQKKJNOVCIXWRD-WDSKDSINSA-N; [M-H]-; (2S,3S)-3-(methoxymethyl)oxolane-2-carbohydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.111; OHRCIKGXPHSEMO-UHFFFAOYSA-N; [M-H]-; 3-methoxy-N-[2-(methylamino)-2-oxoethyl]propanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.111; PIIUEMKPDZXTEW-UHFFFAOYSA-N; [M-H]-; methyl 3-[(2-aminoacetyl)-methylamino]propanoate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.111; YODAZCIDWMNVTB-UHFFFAOYSA-N; [M-H]-; 4-[nitroso(propan-2-yl)amino]butanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.111; WIFIZMCMLKTGBF-UHFFFAOYSA-N; [M-H]-; 3-[2-methylpropyl(nitroso)amino]propanoic acid
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C7H13N2O3; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(2);
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Plasma
AC$INSTRUMENT: Agilent 1290 liquid chromatography system, Agilent Technologies - TripleTOF 6600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 30 eV
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE -4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 20.00; MS2(ppm) 20.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC BEH C18 column (1.7 µm, 2.1 mm x 100 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 7.0 min: 65, 8.0 min: 40, 9.0 min: 40, 9.1 min: 95, 12.0 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.5 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 7.331
MS$FOCUSED_ION: PRECURSOR_M/Z 173.092789
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-000i-2900000000-b62a6586d96c0b7569de
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  76.9690402 284.4377 76.968990 5.2748 46.91 0.8159 16 ?
  136.9356897 999.0000 136.935662 4.3159 0.00 0.8577 17 ?
  154.9460427 261.5515 154.946033 5.5890 53.91 1.0000 17 ?
PK$NUM_PEAK: 3
PK$PEAK: m/z int. rel.int.
  76.969040 284.44 284
  136.935690 999.00 999
  154.946043 261.55 261
//
